drugset / Trial / NCT00061659

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00061659 ↗

Phase 2 Completed 88 enrolled Abbott
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma.

Timeline

Start
2003-05
Primary completion
—
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-510 Peptide — —

Indications